BEAM NASDAQ
Beam Therapeutics Inc.
1W: -6.3%
1M: -12.7%
3M: +0.3%
YTD: +1.9%
1Y: +55.9%
3Y: -18.3%
5Y: -61.5%
$28.64
+0.97 (+3.51%)
Weekly Expected Move ±11.5%
$21
$25
$28
$31
$34
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$164M
Revenue
+158.0% YoY
$-65M
Net Income
+83.2% YoY
$-384M
Free Cash Flow
-6.3% YoY
100.0%
Gross Margin
-337.8%
Op. Margin
-297.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-6.6%
ROA-5.0%
ROIC-102.3%
Valuation
P/E-45.5
P/B2.5
EV/EBITDA-24.0
Leverage
Debt/Equity0.24
Current Ratio13.09
Interest Cov.-8.0x
Quality Scores
Piotroski F5/9
Altman Z5.40
Beneish M-5.57